Onyx Pharmaceuticals to Present at Bank of America 2008 Specialty Pharmaceuticals...

Onyx Pharmaceuticals to Present at Bank of America 2008 Specialty
Pharmaceuticals Conference

EMERYVILLE, Calif., July 31 /PRNewswire-FirstCall/ -- Onyx
Pharmaceuticals, Inc. (Nasdaq: ONXX) today announced that it will present at
the Bank of America 2008 Specialty Pharmaceuticals Conference on Thursday,
August 7, at 3:05 p.m. Eastern Time. Interested parties may access a live
webcast of the presentation on our website at:
http://www.onyx-pharm.com/wt/page/event_calendar
It is recommended that listeners log on 15 minutes early in order to
register and download any necessary software. For those unable to participate
during the live webcast, a recorded replay of the presentation will be
available within 24 hours of the completion of the presentation through
September 7, 2008.
Onyx Pharmaceuticals, Inc. is a biopharmaceutical company committed to
improving the lives of people with cancer by changing the way cancer is
treated(TM). The company, in collaboration with Bayer HealthCare
Pharmaceuticals, Inc., is developing and marketing Nexavar(R), a small
molecule drug. Nexavar is currently approved for the treatment of liver
cancer and advanced kidney cancer. Additionally, Nexavar is being
investigated in several ongoing trials in non-small cell lung cancer,
melanoma, breast cancer, and other cancers. For more information about Onyx,
visit the company's website at http://www.onyx-pharm.com.
Nexavar(R) (sorafenib) tablets is a registered trademark of Bayer
Pharmaceuticals Corporation.
SOURCE Onyx Pharmaceuticals, Inc.

Alex Santos of Onyx Pharmaceuticals, Inc., +1-510-597-6504